Effects of CYP2D6 genetic polymorphism on the pharmacokinetics of metoclopramide-Reference-Cited by-同舟云学术

Effects of CYP2D6 genetic polymorphism on the pharmacokinetics of metoclopramide

Published:2020-11 Issue:11 Volume:43 Page:1207-1213
ISSN:0253-6269
Container-title:Archives of Pharmacal Research
language:en
Short-container-title:Arch. Pharm. Res.

Author:

Bae Jung-Woo,Oh Kyung-Yul,Yoon So-Jung,Shin Hyo-Bin,Jung Eui Hyun,Cho Chang-Keun,Lim Chang Woo,Kang Pureum,Choi Chang-Ik,Jang Choon-Gon,Lee Seok-Yong,Lee Yun Jeong

Funder

National Research Foundation of Korea

Publisher

Springer Science and Business Media LLC

Subject

Organic Chemistry,Drug Discovery,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12272-020-01293-4.pdf

Reference36 articles.

1. Byeon JY, Kim YH, Kim SH, Lee CM, Jung EH, Chae WK, Jang CG, Lee SY, Lee YJ (2018a) The influences of CYP2C9*1/*3 genotype on the pharmacokinetics of zolpidem. Arch Pharm Res 41:931–936. https://doi.org/10.1007/s12272-018-1070-y

2. Byeon JY, Kim YH, Kim SH, Lee CM, Jung EH, Chae WK, Jang CG, Lee SY, Lee YJ (2018b) Effects of genetic polymorphisms of CYP2C19 on the pharmacokinetics of zolpidem. Arch Pharm Res 41:861–866. https://doi.org/10.1007/s12272-018-1065-8

3. Byeon JY, Kim YH, Lee CM, Kim SH, Chae WK, Jung EH, Choi CI, Jang CG, Lee SY, Bae JW, Lee YJ (2018c) CYP2D6 allele frequencies in Korean population, comparison with East Asian, Caucasian and African populations, and the comparison of metabolic activity of CYP2D6 genotypes. Arch Pharm Res 41:921–930. https://doi.org/10.1007/s12272-018-1075-6

4. Byeon JY, Lee YJ, Kim YH, Kim SH, Lee CM, Bae JW, Jang CG, Lee SY, Choi CI (2018d) Effects of diltiazem, a moderate inhibitor of CYP3A4, on the pharmacokinetics of tamsulosin in different CYP2D6 genotypes. Arch Pharm Res 41:564–570. https://doi.org/10.1007/s12272-018-1030-6

5. Byeon JY, Lee CM, Lee YJ, Kim YH, Kim SH, Jung EH, Chae WK, Lee YJ, Jang CG, Lee SY (2019) Influence of CYP2D6 genetic polymorphism on pharmacokinetics of active moiety of tolterodine. Arch Pharm Res 42:182–190. https://doi.org/10.1007/s12272-018-1099-y

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of CYP2D6*2A, CYP2D6*4 and CYP3A5*3 genetic polymorphisms on Bisoprolol peak concentration and clinical response in acute coronary syndrome patients;British Journal of Clinical Pharmacology;2024-06-17

2. PBPK modeling to predict the pharmacokinetics of venlafaxine and its active metabolite in different CYP2D6 genotypes and drug–drug interactions with clarithromycin and paroxetine;Archives of Pharmacal Research;2024-04-25

3. An Unusual Case of an Acute Episode of Restless Leg Syndrome Following Oral Metoclopramide Therapy;Cureus;2024-02-07

4. Effects of CYP2D6 *10 and *41 Variants in Healthy Chinese Men on the Pharmacokinetics of Dapoxetine;The Journal of Clinical Pharmacology;2024-01-04

5. Distribution of CYP2D6 and CYP2C19 gene polymorphisms in Han and Uygur populations with breast cancer in Xinjiang, China;Open Life Sciences;2024-01-01